Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Quote

Third-party claim

“Half of survey respondents plan to add new psychedelic therapies to their practice within six months following FDA approval. However, 60 percent of respondents anticipate barriers to insurance coverage of psychedelic therapy.”
· A New White Paper about Psychedelic Medicine and it's Economics · substack post

From the BrainFutures / CEP press release (which the author says he did not write) about the white paper 'Scaling Psychedelic Therapies in the Health System' that he co-authored: survey of mental health providers in 15 states on plans to adopt psychedelic therapy after FDA approval and expected insurance barriers.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.